Wegovy 2.4 mg Maximum Dose: What Happens When You Reach the Ceiling

You have been injecting once a week for months. You moved through every dose step, managed the nausea, kept going, and you are now at 2.4 mg. Maybe the scale moved steadily until recently. Maybe it has barely shifted at all. Either way, you want to know what actually happens at this ceiling, and what comes next.

The short answer: 2.4 mg is where semaglutide, the active compound in Wegovy, delivers its strongest effect on appetite and body weight. Some people lose steadily from here. Others plateau. Both outcomes happen at this dose, and neither means you are out of options. The STEP 1 trial showed an average weight loss of around 15% of body weight at 2.4 mg over 68 weeks, but that is an average across a large group with different bodies, different baselines, and different metabolic health. Your result may land above or below that figure.

The Dose Escalation Ladder: From 0.25 mg to 2.4 mg

Wegovy follows a fixed titration schedule set by its prescribing label. You start at 0.25 mg weekly for four weeks. That starting dose has no meaningful effect on appetite. Its job is to let your gut adjust before the dose climbs. Every four weeks, the dose steps up: 0.5 mg, then 1.0 mg, then 1.7 mg, then 2.4 mg. That is roughly sixteen to twenty weeks from first injection to maximum dose.

The four-week intervals matter because semaglutide takes roughly four weeks to reach a stable level in your blood at each step. Jumping ahead does not get you to your goal faster. It raises the chance of nausea, vomiting, and other gut side effects. If side effects at any step are difficult, your prescriber can keep you at the current dose for an extra four weeks before moving up. That is a clinical decision, not a failure.

What Your Body Is Doing at the Wegovy Maximum Dose

At 2.4 mg, semaglutide is working at its highest approved level on the GLP-1 receptors in your brain and gut. It slows how fast food leaves your stomach, so hunger signals arrive later. It also acts on appetite-regulating areas in the brain, reducing how rewarding food feels and lowering the drive to eat between meals.

Your body does not stay passive under this. Over time, your metabolism adjusts to a lower calorie intake. This is sometimes called metabolic adaptation. It is not a sign the drug has stopped working. It is your body’s normal response to sustained weight loss. Weight loss often slows after the first several months at 2.4 mg, even when you stay consistent with the medication and your diet.

Why Some People Plateau Before or at 2.4 mg

A plateau at the maximum dose is not unusual. The STEP trials showed that weight loss slows and levels off in most participants well before the 68-week mark, even at 2.4 mg. Your body has a set point, a weight range it works to maintain, and semaglutide shifts that set point downward. Once you reach a new lower set point, further loss requires more effort or intervention.

Several factors shape how much you lose at 2.4 mg. Baseline BMI, insulin resistance, sleep quality, physical activity, and diet all play a role. Genetics affect how strongly your GLP-1 receptors respond. If you are eating well, sleeping reasonably, staying active, and still not moving, this is worth discussing with a doctor rather than cutting more calories on your own.

Should You Stay at 1.7 mg? When 2.4 mg Is Not Always the Target

Not everyone needs to reach 2.4 mg. Some people achieve meaningful, sustained weight loss at 1.7 mg and tolerate it well. If stepping up to 2.4 mg brings significant nausea or other side effects that do not settle within a few weeks, staying at 1.7 mg as a maintenance dose is clinically reasonable. The goal is effective treatment you can stay on, not the highest dose possible.

This decision belongs with your prescriber, based on your response, side effect profile, and progress. If you are losing steadily at 1.7 mg and tolerating it, whether to push higher is a clinical conversation. If weight loss has stalled there without meaningful progress, moving to 2.4 mg is worth the attempt.

Your Options When the Wegovy Maximum Dose Is Not Enough

If you have been at 2.4 mg for at least twelve weeks, your diet and activity are consistent, and weight loss has genuinely stalled, there are evidence-based paths forward. The first is a careful review of what you are actually eating, not calorie counting for its own sake, but looking at food quality, protein intake, and whether any habits have crept back in since you started. This is where working with a doctor makes a real difference.

For some patients, adjunctive medications such as metformin may be considered under medical supervision, depending on their metabolic profile. For others, switching to tirzepatide, which acts on both GLP-1 and GIP receptors, may be worth discussing. Head-to-head data from the SURMOUNT programme suggests tirzepatide produces greater average weight loss than semaglutide at its maximum dose, though individual responses vary and not every patient is a candidate. Any switch requires a proper clinical assessment.

Managing Wegovy on Koh Samui: What Doctor Samui Offers

GLP-1 receptor agonists including semaglutide are prescription medications in Thailand. You cannot buy them over the counter or continue a prescription from home without a licensed Thai physician. For expats living on Samui long-term, and for people who started Wegovy before arriving and need continuity of care, continuing a prescription requires seeing a licensed Thai physician.

Doctor Samui’s GLP-1 programme covers initial consultations, dose review, and ongoing support at any stage of titration, including patients already at the maximum dose. If you have plateaued, we can look at what is driving that clinically and discuss your options. If you need a prescription to continue your injections while living or staying on Koh Samui, we can assess you at the Chaweng clinic or come to your villa or hotel. Appointments are available, including hotel and villa visits across the island.

If you are a long-stay expat managing your weight alongside other health priorities, a health check up in Koh Samui gives us a clearer picture of how your metabolic markers are tracking alongside your GLP-1 therapy. Blood glucose, lipids, and liver function all shift during significant weight loss and are worth monitoring.

What Happens If You Stop at the Maximum Dose

This is the part of the Wegovy conversation that most people find uncomfortable. The STEP 4 trial showed that participants who stopped semaglutide after reaching their maintenance dose regained a significant portion of the weight they had lost within a year. This is not a personal failure. GLP-1 therapy works while you are taking it, and the underlying biological drive toward weight regain does not disappear when you stop the injection.

If you reach 2.4 mg, hit your weight goal, and want to stop, plan that decision carefully with your doctor. Wegovy is contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and should not be used if you have had pancreatitis. Tell your doctor about any severe or persistent abdominal pain, as this can be a sign of pancreatitis and needs prompt medical attention. A supervised taper, continued lifestyle support, and a clear plan for what to do if weight starts to return will give you the best chance of keeping your results. Stopping suddenly without a plan is where most people run into difficulty.